RELATIONLABS
Updating the operating model
- Biotechnology
- January 2026
A4BEE prepared this analysis from publicly available sources. It reflects our own reading of RELATIONLABS's published strategy and is not endorsed by, or produced in cooperation with, RELATIONLABS. Company website
Strategic priorities
RELATIONLABS operates across 4 stated priorities, with the most concrete near-term plan anchored on lab-in-the-loop platform.
Proprietary ActiveGraph ML system integrating wet-lab experiments with computational models through continuous active learning cycles for data-driven target discovery.
Multi-billion dollar collaborations with Novartis ($1.7B), GSK ($300M+), and Deerfield Management validating the platform and creating recurring revenue through milestones.
Access to Cambridge-1 supercomputer enabling large-scale machine learning training and accelerating "time-to-insight" for drug target identification.
-
01
Lab-in-the-Loop Platform
Proprietary ActiveGraph ML system integrating wet-lab experiments with computational models through continuous active learning cycles for data-driven target discovery.
-
02
Strategic Pharma Partnerships
Multi-billion dollar collaborations with Novartis ($1.7B), GSK ($300M+), and Deerfield Management validating the platform and creating recurring revenue through milestones.
-
03
NVIDIA HPC Infrastructure
Access to Cambridge-1 supercomputer enabling large-scale machine learning training and accelerating "time-to-insight" for drug target identification.
-
04
TechBio Transformation
Shifting from traditional luck-based drug discovery to rational, data-driven approaches where computational intelligence guides biological experimentation.
Challenges we see
- Operations R&D Integration
Cross-Disciplinary Workflow Silos
Integration of genomics, data science, and translational medicine disciplines creates significant operational overhead with scientists working in isolated workflows.
Slower hypothesis generation and reduced collaboration efficiency between experimentalists and computational researchers despite shared physical space.
- Digital Data Infrastructure
Multi-Omic Data Scale and Storage
Single-cell sequencing and spatial omics generate petabytes of heterogeneous biological data requiring sophisticated storage and processing architecture.
Computational latency between lab OT and supercomputing IT infrastructure slows down the active learning cycle critical to the Lab-in-the-Loop methodology.
- Digital Data Integrity
Data Quality and Ground-Truth Problem
AI models require high-quality, validated information for training but public datasets are often insufficient, sparse, or contain "batch effects" that reduce model accuracy.
Biological data heterogeneity and noisy public datasets undermine the predictive power of ActiveGraph ML models.
- Compliance Cybersecurity
Secure Data Sharing with Pharma Partners
Partnerships with Novartis and GSK require sharing sensitive discovery data while protecting IP and maintaining GDPR/HIPAA compliance across jurisdictions.
Legal and IP complexities in multi-party data sharing could slow collaboration velocity and expose proprietary genomic sequences.
- Operations Manufacturing
Scaling from Lab to Discovery Factory
The $1.7B Novartis deal and additional partnerships require transitioning from a 5,500 sq ft lab to high-throughput discovery operations managing multiple simultaneous programs.
Current Knowledge Quarter facility may become a bottleneck without industrial-scale automation and workflow orchestration capabilities.
Opportunities, by urgency and business impact
Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.
-
IT/OT Convergence Gap in Lab-in-the-Loop
The Lab-in-the-Loop methodology requires continuous, low-latency data pipelines between physical lab equipment (OT) and NVIDIA HPC clusters (IT), but current integration creates friction in the active learning cycle.
Implement real-time IT/OT convergence architecture enabling smooth data streaming from CRISPR screens and spatial transcriptomics directly to ML model training pipelines.
-
Multi-Omic Data Harmonization
Petabytes of heterogeneous single-cell and spatial omics data exist in disconnected formats with batch effects reducing model accuracy and slowing insight generation.
Deploy ontology-based data platform with automatic pipelines to harmonize multi-omic datasets, ensuring clean and contextualized data flows from sensors to ML models.
-
Cross-Disciplinary Workflow Integration
Geneticists, data scientists, and translational medicine experts work in silos despite shared physical infrastructure, creating operational overhead and slower hypothesis generation.
Implement unified digital R&D platform connecting ELN, LIMS, and computational workflows to enable smooth collaboration between wet-lab and dry-lab teams.
-
Secure Federated Data Sharing
$2B+ in pharma partnerships require sensitive discovery data sharing while maintaining IP protection and regulatory compliance across multiple jurisdictions.
Implement federated learning infrastructure enabling joint model training with Novartis and GSK without exposing proprietary genomic sequences or target candidates.
-
Discovery Factory Scale-Up
Current 5,500 sq ft Knowledge Quarter lab cannot support high-throughput operations required for multiple simultaneous discovery programs under $2B partnership obligations.
Implement Industry 4.0 automation framework with digital twins of the discovery pipeline enabling factory-scale operations while maintaining scientific rigor.
What we'd propose
- Digital Lab
Lab-in-the-Loop Digitalization Platform
Comprehensive digital integration of wet-lab equipment with HPC infrastructure enabling real-time data streaming from CRISPR screens and spatial transcriptomics to ML model training.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Industrial Data Platform for Multi-Omics
Ontology-based data architecture harmonizing petabyte-scale single-cell and spatial omics datasets with automatic pipelines for ML model training.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital Lab
Unified R&D Collaboration Platform
Digital transformation platform eliminating silos between geneticists, data scientists, and translational medicine teams through integrated workflows and shared data environments.
-
Unified data backbone
DETAIL
-
Paperless workflows
DETAIL
-
Continuous QC release
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Enterprise AI
Federated Learning Infrastructure for Pharma Partnerships
Privacy-preserving data sharing architecture enabling joint model training with Novartis and GSK without exposing proprietary genomic sequences or target candidates.
-
Ontology layer
DETAIL
-
Predictive models
DETAIL
-
Decision surfaces
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
- Digital CDMO
Discovery Factory Automation Framework
Industry 4.0 implementation enabling high-throughput discovery operations with automated scheduling, predictive maintenance, and digital twins of the discovery pipeline.
-
OT/IT convergence
DETAIL
-
Batch intelligence
DETAIL
-
Production release flow
DETAIL
- Shorter lead time from data capture to decision.
- Records that audit on their own, not on inspection day.
- Scale without adding the same headcount.
-
Digital maturity: today and target
Scored out of 100 across six dimensions. The target is what RELATIONLABS's own published ambition implies — not a perfect score.
- IT/OT Convergence 45 → 90
- Lab-in-the-Loop requires real-time data streaming to HPC; current latency limits active learning cycle velocity
- Data Harmonization 40 → 85
- Petabyte-scale multi-omic data exists in heterogeneous formats; batch effects reduce model accuracy
- Cross-Team Collaboration 50 → 85
- Physical co-location achieved but digital workflows remain siloed between disciplines
- Cybersecurity & Data Sharing 35 → 85
- $2B partnerships require federated learning and zero trust architecture not yet implemented
- Discovery Automation 30 → 80
- Current lab cannot support high-throughput multi-program operations required by partnerships
- Predictive Analytics 55 → 90
- ActiveGraph ML advanced but production deployment and real-time integration needs maturation
Check this yourself
Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.
-
Self-assessment
Find Your LIMS
Answer a few questions about your lab and get a shortlist of LIMS that fit it.
-
Self-assessment
Data & AI Maturity
See how ready your data actually is for the AI work you're planning.
-
Market comparison
Digital Lab: Equipment & Integration Map
Which lab instruments connect to which systems, and where the gaps usually are.
-
Market comparison
Pharma Data Platform Use Cases — Ranked
Use cases ranked by how hard they are against what they're worth.
Think we've read this right?
Talk to usRelated reading
-
Still biotech or already techbio?
The results of a Tech Imperatives for biotech 2022 report indicate changes in biotech production and management.
-
Developing a data and technology-driven flexible lab operations model
Now, when it becomes clear to the biotech companies that only by sharing the data they can thrive, everyone is looking for a solution.
-
Lab of Tomorrow: We’re at a Turning Point – Is Your Lab on the Right Track?
Do you know what the biggest paradox is? Biotech and pharma fully understand that digitization is the future. Most of them know that effective market competition is simply not possible without artificial intelligence, automation, and data analysis. And yet, many labs are still stuck in the past, working in isolation, manually analyzing data, and losing the potential that technology offers.
-
Zero Trust Security Principles
The drive to find new resources for innovation and process improvement in life science companies is becoming more based on technologies.
-
Digital Twin Maturity Model – self-assessment tool
Initially, defining what a digital twin even is seemed simple - we have a real product and its virtual counterpart, and we combine the two.
This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with RELATIONLABS, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].